|[June 18, 2012]
Elekta: Elekta's Nomination Committee proposal for the Election of Board of Directors and Auditors to the Annual General Meeting 2012
STOCKHOLM --(Business Wire)--
The Nomination Committee of Elekta AB (publ)(STO:EKTAB) proposes the
following to the company's Annual General Meeting on September 4, 2012.
The Nomination Committee of Elekta AB (publ) proposes that the Board of
Directors consists of eight members. The Nomination Committee proposes
the re-election of Akbar Seddigh, Hans Barella, Luciano Cattani, Laurent
Leksell, Siaou-Sze Lien, Wolfgang Reim, Jan Secher and Birgitta Stymne
Göransson as members of the Board. Furthermore, the Nomination Committee
also proposes that Akbar Seddigh is re-appointed Chairman of the Board.
The Nomination Committee proposes that PwC is elected as the Company's
auditor, with Authorized Public Accountant Johan Engstam as auditor in
The complete proposal of the Nomination Committee for resolution at the
Annual General Meeting on September 4, 2012 will be presented in the
notice of the Annual General Meeting.
The Nomination Committee conists of Laurent Leksell (Chairman), private
and companies' holdings; Åsa Nisell, Swedbank Robur funds, Anna
Ohlsson-Leijon, SEB Funds; Ingrid Bonde, AMF Insurance and Funds; and
Akbar Seddigh, Chairman of the Board.
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 07:30 CET on
June 18, 2012.
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,300 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker EKTAb.
This information was brought to you by Cision http://www.cisionwire.com
[ Back To TMCnet.com's Homepage ]